New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival.

There have been numerous epidemiologic investigations to determine factors that may affect cancer risk. There is also a rich tradition of evaluating potential somatic changes in the cancer itself to predict recurrence and/or mortality after diagnosis. However, there has been relatively little